Rise in investor sentiment, return of risk appetite aid shares across the board
Big bull's holdings cross Rs 7,200 crore (Rs 72 billion).
Markets ended lower amid volatile trade with Sun Pharma leading the decline.
Short-covering and the propping up of net asset values have potential to boost frontline as well as second-rung names next week
The 30-share Sensex ended down 224 points at 28,442 and the 50-share Nifty ended down 101 points at 8,606.
Rate-sensitive sectors like banks, auto and realty witnessed strong buying demand in trades today
Large and small businesses alike have delivered low-key performances.
Index heavyweight RIL surged 3% to end above Rs 1,000 mark while IT majors were also the top gainers.
FDA allows Teva to launch Nexium generic; Cipla, which supplies formulation, to gain
Natco Pharma, Wockhardt and Marksans have rallied between 50 and 70 per cent in the year till date.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
The country's drug companies have attracted the highest number of enforcements from the American drug regulator in 2013, a year that has seen the US Food and Drug Administration turning stricter to ensure compliance levels and quality of medicines.
In a big shot in the arm for the YSR Congress party in Andhra Pradesh, a Central Bureau of Investigation court in Hyderabad on Monday granted conditional bail to its president and Member of Lok Sabha YS Jaganmohan Reddy in disproportionate assets case.
Sensex, Nifty put up a good show in closing trade.
The FMCG index gained more than 1% on the back of stellar gains in ITC.
Revival in domestic business should also help overall revenue growth.
Ajit Mishra, Vice President, Research, Religare Broking, answers readers's queries on stocks they own or want to buy.
The number of small units has come down drastically, as large companies have expanded their manufacturing capacity.
An expectation of tax sops in Budget, weakness of dollar and robust tax collection are adding positive sentiment
Market breadth continued to remain strong, with 1899 gainers and 674 losers on the BSEs.
Investors turn their attention to export-driven sectors.
The rally in index heavyweight ITC has boosted the sentiment across the board.
The policy statement by the RBI governor is also expected to be upbeat.
The Sensex ended below 28,000 for the second straight day at 27,869.
The WPI inflation stood at negative 2.4% in May 2015, compared with a negative 2.65% in April 2015.
Investors remain cautious ahead of F&O expiry.
The Nifty had hit its third successive record high of 7,922.70 today.
Ajit Mishra, Vice President, Research, Religare Broking, answers readers' queries on stocks they own or want to buy.
Markets in green tracking firm global cues.
And when an inspector asked about the contents of unlabelled vials in the laboratory glassware washing area, a plant worker dumped them down a sink and said the contents could not be determined, according to a July 18 letter from the US Food and Drug Administration to Wockhardt, which makes sterile injectable drugs and various forms of insulin.
In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.
T N Ninan lists a few David-Goliath encounters in the Indian markets, all of which make life interesting, though difficult if you are an investor looking for the next multi-bagger.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances